These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6834349)

  • 21. International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 microg and ethinyl estradiol 20 microg.
    Boerrigter PJ; Ellman H; Dolker M
    Clin Ther; 1999 Jan; 21(1):118-27. PubMed ID: 10090429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacological aspects of oral contraceptives (author's transl)].
    Weil-levy C; Soubrie C; Simon P
    Contracept Fertil Sex (Paris); 1980 Feb; 8(2):123-7. PubMed ID: 12336185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endometrial interference of synthetic estrogens in fertility regulation.Is it necessary to interfere with the antiovulatory mechanism at the central nervous system level in order to obtain contraception?].
    Sojo Aranda QI; Rojas T; Cortés-Gallegos V
    Ginecol Obstet Mex; 1997 Oct; 65():449-51. PubMed ID: 9432479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol.
    Anderson FD; Gibbons W; Portman D
    Contraception; 2006 Mar; 73(3):229-34. PubMed ID: 16472561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sex steroids and vascular risk].
    Rozenbaum H
    Coeur; 1983; 14(1):91-102. PubMed ID: 12339512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular biology and oral contraception.
    Briggs MH; Briggs M
    N Z Med J; 1976 Apr; 83(562):257-61. PubMed ID: 183175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pros and cons of triphasic oral contraception].
    Berdah J
    Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract]   [Full Text] [Related]  

  • 33. [Choosing contraception for adolescents].
    Wemeau-jacquemont C
    NPN Med; 1985 Feb; 5(84):185-9. PubMed ID: 12280585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].
    Rossmanith WG; Wirth U; Gasser S; Thun B; Steffens D
    Zentralbl Gynakol; 1997; 119(11):538-44. PubMed ID: 9480608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
    Endrikat J; Blode H; Gerlinger C; Rosenbaum P; Kuhnz W
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Estrogens in contraception].
    Lauritzen C
    Wien Med Wochenschr; 1987 Oct; 137(18-19):427-32. PubMed ID: 3318154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Estrogens. Contraceptive therapy].
    Sojo-Aranda I; Cortés-Gallegos V
    Ginecol Obstet Mex; 1995 Jan; 63():46-9. PubMed ID: 7896159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral contraceptives: clinical pharmacology, composition, choice of preparation].
    Hammerstein J
    Wien Med Wochenschr; 1987 Oct; 137(18-19):441-9. PubMed ID: 3318156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.